Which laboratory tests should be obtained to evaluate low testosterone and investigate secondary (hypothalamic‑pituitary) causes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Evaluation for Secondary Causes of Low Testosterone

When low testosterone is confirmed with two morning measurements <300 ng/dL, measure serum LH and FSH to distinguish primary from secondary hypogonadism, then obtain prolactin if gonadotropins are low or low-normal to screen for pituitary pathology. 1, 2

Essential Initial Hormone Panel

Gonadotropins (LH and FSH)

  • Measure serum LH and FSH in all patients with confirmed low testosterone to differentiate primary (testicular) from secondary (hypothalamic-pituitary) hypogonadism 1, 3
  • Low or inappropriately normal LH/FSH with low testosterone indicates secondary hypogonadism, whereas elevated LH/FSH indicates primary hypogonadism 2, 3
  • This distinction is critical because secondary hypogonadism can be treated with gonadotropin therapy to restore both testosterone and fertility, while primary hypogonadism requires testosterone replacement which permanently suppresses fertility 2

Prolactin

  • Measure serum prolactin in all patients with low testosterone and low or low-normal LH levels to screen for hyperprolactinemia 1, 3
  • If prolactin is elevated, repeat the measurement to confirm it is not spurious 1
  • Persistently elevated prolactin (>1.5× upper limit of normal) requires referral to endocrinology and pituitary MRI to evaluate for prolactinoma 1, 2

Free Testosterone and SHBG

  • Measure free testosterone by equilibrium dialysis and SHBG in men with total testosterone near the lower limit of normal (231-346 ng/dL) or in obese patients where SHBG abnormalities are common 2, 3, 4
  • In men with elevated SHBG (e.g., from liver disease, hyperthyroidism), calculate the free androgen index (total testosterone ÷ SHBG × 100); an FAI <30 indicates true hypogonadism even when total testosterone appears borderline-normal 2
  • Avoid direct immunoassays for free testosterone as they are unreliable; use equilibrium dialysis or validated calculation formulas 2, 5

Pituitary Imaging Indications

  • Order pituitary MRI when total testosterone is <150 ng/dL with LH/FSH <1.5 IU/L, regardless of prolactin level, as non-secreting adenomas may be present 1, 2
  • MRI is also indicated for prolactin >1.5× upper limit of normal, visual field defects (bitemporal hemianopsia), or anosmia 1, 2, 6

Additional Screening for Reversible Causes

Metabolic and Systemic Conditions

  • Measure fasting glucose and HbA1c to screen for diabetes, which is strongly associated with secondary hypogonadism 2, 6
  • Check TSH to exclude thyroid dysfunction that can mimic hypogonadal symptoms and alter SHBG 2, 3
  • Obtain iron saturation and ferritin if hemochromatosis is suspected, as iron overload causes secondary hypogonadism 2

High-Risk Populations Requiring Testing

  • Measure testosterone even without symptoms in men with unexplained anemia, bone density loss, diabetes, chemotherapy exposure, testicular radiation, HIV, chronic narcotic use, chronic corticosteroid use, or pituitary disorders 1, 6

Diagnostic Algorithm Summary

  1. Confirm hypogonadism: Two separate fasting morning (8-10 AM) total testosterone measurements <300 ng/dL using the same laboratory 1, 2, 3

  2. Measure LH and FSH to classify primary vs. secondary hypogonadism 1, 3

  3. If LH/FSH are low or low-normal: measure prolactin 1, 3

  4. If testosterone <150 ng/dL with LH/FSH <1.5 IU/L or prolactin >1.5× ULN: order pituitary MRI 1, 2

  5. If total testosterone is 231-346 ng/dL or patient is obese: measure free testosterone by equilibrium dialysis and SHBG 2, 3, 4

  6. Screen for reversible causes: fasting glucose, HbA1c, TSH, and iron studies as clinically indicated 2, 3

Critical Pitfalls to Avoid

  • Never diagnose hypogonadism on a single testosterone measurement; two morning values are required due to diurnal variation and assay variability 1, 3, 7
  • Never omit LH/FSH testing after confirming low testosterone, as the distinction between primary and secondary hypogonadism directs treatment and fertility counseling 1, 2
  • Do not measure testosterone outside the 8-10 AM window; only 9% of tested men have appropriately timed samples, leading to diagnostic errors 7
  • Do not rely on direct immunoassays for free testosterone in men with abnormal SHBG; use equilibrium dialysis or validated calculation methods 2, 5
  • Do not skip pituitary imaging when testosterone is <150 ng/dL with low gonadotropins, as this may miss treatable pituitary lesions 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Testosterone Injection Treatment for Male Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Evaluation and Management of Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Accurate Measurement and Harmonized Reference Ranges for Total and Free Testosterone Levels.

Endocrinology and metabolism clinics of North America, 2022

Guideline

Clinical Indications for Suspecting Low Testosterone (Hypogonadism)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What laboratory tests are ordered to evaluate suspected low testosterone?
Should free testosterone or total testosterone be tested first in patients with suspected hypogonadism (testosterone deficiency)?
What is the recommended protocol for initiating and monitoring testosterone replacement therapy in men with testosterone deficiency and erectile dysfunction, including baseline and follow‑up laboratory tests, timing of repeat labs, and indications and timing for pituitary MRI or scrotal ultrasound?
What are the initial steps for androgen (male hormone) testing and treatment?
What is the management approach for a male with low morning testosterone and free testosterone levels?
What is the recommended approach to screen adults aged 40‑75 for cardiovascular disease risk, including which measurements, laboratory tests, risk calculators, and screening intervals?
What is the appropriate emergent evaluation and management for an 82‑year‑old woman presenting with new headache, ear pain, and photophobia?
What is the recommended management and treatment regimen for Dressler syndrome?
For an asymptomatic adult aged 40‑75 years without known atherosclerotic cardiovascular disease and a 10‑year ASCVD risk of 5‑20 %, when is a coronary artery calcium (CAC) scan indicated?
Do most U.S. insurance plans cover Repatha (evolocumab) for a statin‑intolerant patient with low‑density lipoprotein cholesterol > 190 mg/dL?
Is it safe to co‑administer a tricyclic antidepressant (e.g., amitriptyline, nortriptyline, imipramine) with hyoscyamine in a patient with irritable bowel syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.